The DOI matches its Crossref record; 333 of the 333 references it cites were found in a registry or an index.
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
Abstract
Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Judgment under Uncertainty: Heuristics and Biases
Tversky, A., & Kahneman, D. (1975) · Utility, Probability, and Human Decision Making · doi:10.1007/978-94-010-1834-0_8 · Cited by 22,650
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub5 · Cited by 6,685
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938
Trumbo (2001) · doi:10.1016/s0002-8223(01)00078-5 · Cited by 4,852
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Department of Health, Education, and Welfare
Cooper, T. (1976) · Military Medicine · doi:10.1093/milmed/141.8.521 · Cited by 3,993
Kay, H. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.6.608-c · Cited by 3,809
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Health Literacy: A Prescription to End Confusion
Committee on Health Literacy, Board on Neuroscience and Behavioral Health, & Institute of Medicine (2004) · doi:10.17226/10883 · Cited by 3,444
Self-citationRubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence
Block, G., Patterson, B., & Subar, A. (1992) · Nutrition and Cancer · doi:10.1080/01635589209514201 · Cited by 3,238
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707233170401 · Cited by 2,995
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Scher, H. I., Halabi, S., Tannock, I., Morris, M., Sternberg, C. N., Carducci, M. A., Eisenberger, M. A., Higano, C., Bubley, G. J., Dreicer, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4487 · Cited by 2,241
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., Neumann, F.-J., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,103
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Pathophysiology of coronary artery disease
Libby, P., & Theroux, P. (2005) · Circulation · doi:10.1161/circulationaha.105.537878 · Cited by 1,965
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Effectiveness and Efficiency: Random Reflections on Health Services
(1973) · Public Health · doi:10.1016/s0033-3506(73)80082-4 · Cited by 1,912
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Identifiability and exchangeability for direct and indirect effects
Robins, J. M., & Greenland, S. (1992) · Epidemiology · doi:10.1097/00001648-199203000-00013 · Cited by 1,793
Clofibrate and Niacin in Coronary Heart Disease
(1975) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1975.03240160024021 · Cited by 1,747
Nissen, S. E., Tsunoda, T., Tuzcu, E. M., Schoenhagen, P., Cooper, C. J., Yasin, M., Eaton, G. M., Lauer, M. A., Sheldon, W. S., Grines, C. L., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2292 · Cited by 1,707
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
Llovet, J. M., Di Bisceglie, A. M., Bruix, J., Kramer, B. S., Lencioni, R., Zhu, A. X., Sherman, M., Schwartz, M., Lotze, M., Talwalkar, J., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn134 · Cited by 1,653
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.1986.03380200073024 · Cited by 1,611
Can dietary beta-carotene materially reduce human cancer rates?
Peto, R., Doll, R., Buckley, J. D., & Sporn, M. B. (1981) · Nature · doi:10.1038/290201a0 · Cited by 1,563
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Choi, H., Charnsangavej, C., Faria, S. C., Macapinlac, H. A., Burgess, M. A., Patel, S. R., Chen, L. L., Podoloff, D. A., & Benjamin, R. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3049 · Cited by 1,520
Principal Stratification in Causal Inference
Frangakis, C. E., & Rubin, D. B. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00021.x · Cited by 1,511
Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot, U. N. (2003) · JAMA · doi:10.1001/jama.290.7.898 · Cited by 1,494
Clinical practice guidelines : directions for a new program
Field, M. J., & Lohr, K. N. (1990) · Cited by 1,415
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Manninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Bigger, J. T., Fleiss, J. L., Kleiger, R., Miller, J. P., & Rolnitzky, L. M. (1984) · Circulation · doi:10.1161/01.cir.69.2.250 · Cited by 1,286
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1550 · Cited by 1,255
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Edelman, R. R., & Warach, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303183281109 · Cited by 1,206
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events
Greenland, P. (2003) · JAMA · doi:10.1001/jama.290.7.891 · Cited by 1,050
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
Current databases on biological variation: pros, cons and progress
C. Ricós, V. A. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519950185229 · Cited by 987
Plasma cholesteryl ester transfer protein
Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
The Role of Lipids and Lipoproteins in Atherosclerosis
Gofman, J. W., Lindgren, F., Elliott, H., Mantz, W., Hewitt, J., Strisower, B., Herring, V., & Lyon, T. P. (1950) · Science · doi:10.1126/science.111.2877.166 · Cited by 918
A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease
Omland, T., de Lemos, J. A., Sabatine, M. S., Christophi, C. A., Rice, M. M., Jablonski, K. A., Tjora, S., Domanski, M. J., Gersh, B. J., Rouleau, J. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805299 · Cited by 901
Albanes, D., Heinonen, O. P., Taylor, P. R., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Palmgren, J., Freedman, L. S., Haapakoski, J., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1560 · Cited by 901
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., & Tall, A. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231803 · Cited by 861
Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R. (2008) · Circulation · doi:10.1161/circulationaha.108.814251 · Cited by 841
Genetically elevated C-reactive protein and ischemic vascular disease
Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707402 · Cited by 839
Lipid Research Clinics Program
Renfrew, R. A. (1984) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1984.03350180015009 · Cited by 829
Conflict of Interest in Medical Research, Education, and Practice
(2009) · National Academies Press eBooks · doi:10.17226/12598 · Cited by 807
Lipkus, I. M. (2007) · Medical Decision Making · doi:10.1177/0272989x07307271 · Cited by 771
Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement
Lee, J. W., Devanarayan, V., Barrett, Y. C., Weiner, R., Allinson, J., Fountain, S., Keller, S., Weinryb, I., Green, M., Duan, L., et al. (2006) · Pharmaceutical Research · doi:10.1007/s11095-005-9045-3 · Cited by 768
Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention
Pai, V. B., & Nahata, M. C. (2000) · Drug Safety · doi:10.2165/00002018-200022040-00002 · Cited by 729
Latini, R., Masson, S., Anand, I. S., Missov, E., Carlson, M., Vago, T., Angelici, L., Barlera, S., Parrinello, G., Maggioni, A. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655076 · Cited by 709
Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve
Cook, N. R. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.096529 · Cited by 691
Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) · Nature · doi:10.1038/nature04672 · Cited by 672
Ventricular Premature Beats and Mortality after Myocardial Infarction
Ruberman, W., Weinblatt, E., Goldberg, J. D., Frank, C. W., & Shapiro, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197710062971404 · Cited by 660
Morrow, D. A. (2001) · JAMA · doi:10.1001/jama.286.19.2405 · Cited by 656
Biological Variation: From Principles to Practice
Fraser, C. G. (2001) · Cited by 653
It’s Time for a Change to a Troponin Standard
Jaffe, A. S., Ravkilde, J., Roberts, R., Naslund, U., Apple, F. S., Galvani, M., & Katus, H. (2000) · Circulation · doi:10.1161/01.cir.102.11.1216 · Cited by 643
Literacy and misunderstanding prescription drug labels
Davis, T. C., Wolf, M. S., Bass, P. F., Thompson, J. A., Tilson, H. H., Neuberger, M., & Parker, R. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-12-200612190-00144 · Cited by 628
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 623
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107331 · Cited by 622
NACB WRITING GROUP MEMBERS, Morrow, D. A., Cannon, C. P., Jesse, R. L., Newby, L. K., Ravkilde, J., Storrow, A. B., Wu, A. H. B., & Christenson, R. H. (2007) · Circulation · doi:10.1161/circulationaha.107.182882 · Cited by 610
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 599
HDL and arteriosclerosis: beyond reverse cholesterol transport
Nofer, J.-R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G., & Eckardstein, A. V. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00651-7 · Cited by 595
Verschuren, W. M. M. (1995) · JAMA · doi:10.1001/jama.1995.03530020049031 · Cited by 573
Patient Understanding of Food Labels
Rothman, R. L., Housam, R., Weiss, H., Davis, D., Gregory, R., Gebretsadik, T., Shintani, A., & Elasy, T. A. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.07.025 · Cited by 563
Predictive Value of Cardiac Troponin I and T for Subsequent Death in End-Stage Renal Disease
Apple, F. S., Murakami, M. M., Pearce, L. A., & Herzog, C. A. (2002) · Circulation · doi:10.1161/01.cir.0000041254.30637.34 · Cited by 559
We Should Desist Using RECIST, at Least in GIST
Benjamin, R. S., Choi, H., Macapinlac, H. A., Burgess, M. A., Patel, S. R., Chen, L. L., Podoloff, D. A., & Charnsangavej, C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3411 · Cited by 559
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Tricca LabTech, A., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Cipolla, C. M., & Fiorentini, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00748-8 · Cited by 551
Risk factors for sudden death after acute myocardial infarction: Two-year follow-up
Mukharji, J., Rude, R. E., Poole, W. K., Gustafson, N., Thomas, L. J., Strauss, H. W., Jaffe, A. S., Muller, J. E., Roberts, R., Raabe, D. S., et al. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90299-6 · Cited by 545
Vitamin D fortification in the United States and Canada: current status and data needs
Calvo, M. S., Whiting, S. J., & Barton, C. N. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1710s · Cited by 519
Roe, B., Levy, A. S., & Derby, B. M. (1999) · Journal of Public Policy & Marketing · doi:10.1177/074391569901800110 · Cited by 506
Staessen, J. A., Wang, J.-G., & Thijs, L. (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00002 · Cited by 487
Cook, N. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1610 · Cited by 479
Cardiac Troponin T in Patients With Clinically Suspected Myocarditis
Lauer, B., Niederau, C., Kühl, U., Schannwell, M., Pauschinger, M., Strauer, B.-E., & Schultheiss, H.-P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00317-3 · Cited by 477
Maynard, C. D., Bryan, R. N., & Hattery, R. R. (2000) · Radiology · doi:10.1148/radiology.214.1.r00ja5510 · Cited by 476
Total cholesterol and risk of mortality in the oldest old
Weverling-Rijnsburger, A. W., Blauw, G. J., Lagaay, A. M., Knock, D. L., Meinders, A. E., & Westendorp, R. G. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04430-9 · Cited by 474
Lee, I.-M., Cook, N. R., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2102 · Cited by 467
Numeracy Skill And The Communication, Comprehension, And Use Of Risk-Benefit Information
Peters, E., Hibbard, J., Slovic, P., & Dieckmann, N. (2007) · Health Affairs · doi:10.1377/hlthaff.26.3.741 · Cited by 466
Lesko, L., & Atkinson, A. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.347 · Cited by 465
BARTER, P. J., BALLANTYNE, C. M., CARMENA, R., CABEZAS, M. C., CHAPMAN, M. J., COUTURE, P., DE GRAAF, J., DURRINGTON, P. N., FAERGEMAN, O., FROHLICH, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 464
Lin, N. U., Carey, L. A., Liu, M. C., Younger, J., Come, S. E., Ewend, M., Harris, G. J., Bullitt, E., Van den Abbeele, A. D., Henson, J. W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3588 · Cited by 456
Nauck, M., Warnick, G. R., & Rifai, N. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.236 · Cited by 442
A New Season for Cardiac Troponin Assays: It’s Time to Keep a Scorecard
Apple, F. S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.128363 · Cited by 438
Prevalence and Determinants of Troponin T Elevation in the General Population
Wallace, T. W., Abdullah, S. M., Drazner, M. H., Das, S. R., Khera, A., McGuire, D. K., Wians, F., Sabatine, M. S., Morrow, D. A., & de Lemos, J. A. (2006) · Circulation · doi:10.1161/circulationaha.105.609974 · Cited by 434
An Overview Of Cardiovascular Disease Burden In The United States
Mensah, G. A., & Brown, D. W. (2007) · Health Affairs · doi:10.1377/hlthaff.26.1.38 · Cited by 429
Schatz, I. J., Masaki, K., Yano, K., Chen, R., Rodriguez, B. L., & Curb, J. D. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05553-2 · Cited by 426
Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
Buyse, M., & Molenberghs, G. (1998) · Biometrics · doi:10.2307/2533853 · Cited by 425
RECIST revisited: A review of validation studies on tumour assessment
Therasse, P., Eisenhauer, E. A., & Verweij, J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.026 · Cited by 422
Blood Lipids and Human Atherosclerosis
GOFMAN, J. W., JONES, H. B., LINDGREN, F. T., LYON, T. P., ELLIOTT, H. A., & STRISOWER, B. (1950) · Circulation · doi:10.1161/01.cir.2.2.161 · Cited by 417
Heidenreich, P. A., Alloggiamento, T., McDonald, K. M., Go, A. S., Hlatky, M. A., & Melsop, K. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01388-2 · Cited by 406
Cardiac troponin I in pre‐eclampsia and gestational hypertension
Fleming, S. M., O'Gorman, T., Finn, J., Grimes, H., Daly, K., & Morrison, J. J. (2000) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11658.x · Cited by 399
Consumer Understanding and Use of Health Claims for Foods
Williams, P. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00382.x · Cited by 398
A Classification of Unstable Angina Revisited
Hamm, C. W., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.1.118 · Cited by 394
Circulating Cardiac Troponin I in Severe Congestive Heart Failure
Missov, E., Calzolari, C., & Pau, B. (1997) · Circulation · doi:10.1161/01.cir.96.9.2953 · Cited by 390
FACTORS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
GOLDBERG, J., FLOWERDEW, G., SMITH, E., BRODY, J. A., & TSO, M. O. M. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115023 · Cited by 384
Novel Inflammatory Markers of Coronary Risk: Theory Versus Practice
Libby, P., & Ridker, P. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1148 · Cited by 375
C-Reactive Protein Accelerates the Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice
Paul, A., Ko, K. W. S., Li, L., Yechoor, V., McCrory, M. A., Szalai, A. J., & Chan, L. (2004) · Circulation · doi:10.1161/01.cir.0000114526.50618.24 · Cited by 373
Epidemiology of Uncontrolled Hypertension in the United States
Wang, T. J., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.104.490599 · Cited by 369
C‐reactive protein and coronary heart disease: a critical review
Casas, J. P., Shah, T., Hingorani, A. D., Danesh, J., & Pepys, M. B. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02015.x · Cited by 366
Manninen, V., Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Op, H., & Frick, H. M. (1992) · Circulation · Cited by 360
Folsom, A. R., Chambless, L. E., Ballantyne, C. M., Coresh, J., Heiss, G., Wu, K. K., Boerwinkle, E., Mosley, T. H., Sorlie, P., Diao, G., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1368 · Cited by 358
Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research
Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy Rule, Board on Health Sciences Policy, Board on Health Care Services, & Institute of Medicine (2009) · RePEc: Research Papers in Economics · doi:10.17226/12458 · Cited by 356
The Ethics of Placebo-Controlled Trials — A Middle Ground
Emanuel, E. J., & Miller, F. G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451211 · Cited by 352
A survey of 246 suggested coronary risk factors
Hopkins, P. N., & Williams, R. R. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90122-2 · Cited by 351
Lipids, risk factors and ischaemic heart disease
Castelli, W. P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05851-0 · Cited by 337
Clinical Implications of Numeracy: Theory and Practice
Nelson, W., Reyna, V. F., Fagerlin, A., Lipkus, I., & Peters, E. (2008) · Annals of Behavioral Medicine · doi:10.1007/s12160-008-9037-8 · Cited by 329
Kummar, S., Kinders, R., Gutierrez, M. E., Rubinstein, L., Parchment, R. E., Phillips, L. R., Ji, J., Monks, A., Low, J. A., Chen, A., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7681 · Cited by 326
Sharma, U., Danishad, K. K. A., Seenu, V., & Jagannathan, N. R. (2009) · NMR in Biomedicine · doi:10.1002/nbm.1245 · Cited by 321
Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Borghini, E., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Fiorentini, C., & Cipolla, C. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf170 · Cited by 313
A Definition and Operational Framework for Health Numeracy
GOLBECK, A., AHLERSSCHMIDT, C., PASCHAL, A., & DISMUKE, S. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.06.012 · Cited by 292
Zethelius, B., Johnston, N., & Venge, P. (2006) · Circulation · doi:10.1161/circulationaha.105.570762 · Cited by 280
Shepherd, J., Blauw, G. J., & Murphy, M. B. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00040-0 · Cited by 273
Liu, S., Lee, I.-M., Ajani, U., Cole, S. R., Buring, J. E., & Manson, J. E. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.1.130 · Cited by 270
Assessing Tumor Response to Therapy
Weber, W. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057174 · Cited by 269
Albert, M. A., Glynn, R. J., Buring, J., & Ridker, P. M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.067 · Cited by 259
Kronmal, R. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410090025004 · Cited by 253
Surrogate Endpoints And FDA’s Accelerated Approval Process
Fleming, T. R. (2005) · Health Affairs · doi:10.1377/hlthaff.24.1.67 · Cited by 249
Ledue, T. B., & Rifai, N. (2003) · Clinical Chemistry · doi:10.1373/49.8.1258 · Cited by 242
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
Sacks, F. M., & Campos, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030636 · Cited by 241
Jiang, R., Schulze, M. B., Li, T., Rifai, N., Stampfer, M. J., Rimm, E. B., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1991 · Cited by 238
Shah, T., Casas, J. P., Cooper, J. A., Tzoulaki, I., Sofat, R., McCormack, V., Smeeth, L., Deanfield, J. E., Lowe, G. D., Rumley, A., et al. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn217 · Cited by 238
The Cardiac Arrhythmia Pilot Study (CAPS) investigators (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90754-0 · Cited by 236
Yamada, S. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.12.1183 · Cited by 235
Activation of Inflammation and Coagulation After Infusion of C-Reactive Protein in Humans
Bisoendial, R. J., Kastelein, J. J. P., Levels, J. H. M., Zwaginga, J. J., van den Bogaard, B., Reitsma, P. H., Meijers, J. C. M., Hartman, D., Levi, M., & Stroes, E. S. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163015.67711.ab · Cited by 234
The Cardiac Arrhythmia Suppression Trial (CAST)
Ruskin, J. N. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210608 · Cited by 233
Stacchiotti, S., Collini, P., Messina, A., Morosi, C., Barisella, M., Bertulli, R., Piovesan, C., Dileo, P., Torri, V., Gronchi, A., et al. (2009) · Radiology · doi:10.1148/radiol.2512081403 · Cited by 233
Griffin, J. H., Kojima, K., Banka, C. L., Curtiss, L. K., & Fernández, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5006 · Cited by 232
The New Sentinel Network — Improving the Evidence of Medical-Product Safety
Platt, R., Wilson, M., Chan, K. A., Benner, J. S., Marchibroda, J., & McClellan, M. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0905338 · Cited by 228
Schwarz, J., Bader, M., Jenicke, L., Hemminger, G., Jänicke, F., & Avril, N. E. (2005) · PubMed · Cited by 227
Issues in the Registration of Clinical Trials
Zarin, D. A., Ide, N. C., Tse, T., Harlan, W. R., West, J. C., & Lindberg, D. A. B. (2007) · JAMA · doi:10.1001/jama.297.19.2112 · Cited by 222
Measuring Response in Solid Tumors: Comparison of RECIST and WHO Response Criteria
Park, J. O. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg093 · Cited by 222
Postmarketing Surveillance—Lack of Vigilance, Lack of Trust
Fontanarosa, P. B. (2004) · JAMA · doi:10.1001/jama.292.21.2647 · Cited by 221
Lindvall, C., & Lask, B. (2011) · Eating Disorders and the Brain · doi:10.1002/9781119998402.ch10 · Cited by 218
Lipoproteins and Atherosclerosis
Gofman, J. W., Lindgren, F. T., Jones, H. B., Lyon, T. P., & Strisower, B. (1951) · Journal of Gerontology · doi:10.1093/geronj/6.2.105 · Cited by 207
Vitamin D Intakes by Children and Adults in the United States Differ among Ethnic Groups
Moore, C. E., Murphy, M. M., & Holick, M. F. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.10.2478 · Cited by 206
Related Causal Frameworks for Surrogate Outcomes
Joffe, M. M., & Greene, T. (2009) · Biometrics · doi:10.1111/j.1541-0420.2008.01106.x · Cited by 203
Wagner, J. A., Williams, S. A., & Webster, C. J. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100017 · Cited by 201
Strength of Study Evidence Examined by the FDA in Premarket Approval of Cardiovascular Devices
Dhruva, S. S. (2009) · JAMA · doi:10.1001/jama.2009.1899 · Cited by 198
Lee, J. W., Weiner, R. S., Sailstad, J. M., Bowsher, R. R., Knuth, D. W., O’Brien, P. J., Fourcroy, J. L., Dixit, R., Pandite, L., Pietrusko, R. G., et al. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2495-9 · Cited by 193
Psaty, B. M., Furberg, C. D., Ray, W. A., & Weiss, N. S. (2004) · JAMA · doi:10.1001/jama.292.21.2622 · Cited by 192
Ratain, M. J., Mick, R., Schilsky, R. L., & Siegler, M. (1993) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/85.20.1637 · Cited by 190
Robins, J. M., & Greenland, S. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476807 · Cited by 185
The use of high-sensitivity assays for C-reactive protein in clinical practice
Musunuru, K., Kral, B. G., Blumenthal, R. S., Fuster, V., Campbell, C. Y., Gluckman, T. J., Lange, R. A., Topol, E. J., Willerson, J. T., Desai, M. Y., et al. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1322 · Cited by 182
Quality Specifications for B-Type Natriuretic Peptide Assays
Apple, F. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.044594 · Cited by 178
Roberts, W. L. (2004) · Circulation · doi:10.1161/01.cir.0000148986.52696.07 · Cited by 178
Serum antioxidant vitamins and risk of cataract.
Knekt, P., Heliövaara, M., Rissanen, A., Aromaa, A., & Aaran, R. K. (1992) · BMJ · doi:10.1136/bmj.305.6866.1392 · Cited by 177
Demographics and cardiology, 1950–2050
Foot, D. K., Lewis, R. P., Pearson, T. A., & Beller, G. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00561-1 · Cited by 177
Karrison, T. G., Maitland, M. L., Stadler, W. M., & Ratain, M. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm158 · Cited by 177
Issues in Using Progression-Free Survival When Evaluating Oncology Products
Fleming, T. R., Rothmann, M. D., & Lu, H. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4107 · Cited by 176
Musunuru, K., Orho-Melander, M., Caulfield, M. P., Li, S., Salameh, W. A., Reitz, R. E., Berglund, G., Hedblad, B., Engström, G., Williams, P. T., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.190405 · Cited by 168
Surrogate endpoints: A basis for a rational approach
Boissel, J. P., Collet, J. P., Moleur, P., & Haugh, M. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02333016 · Cited by 166
Surrogate endpoints in clinical trials: Cancer
Ellenberg, S. S., & Hamilton, J. M. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080404 · Cited by 166
Numeracy and Communication with Patients: They Are Counting on Us
Apter, A. J., Paasche‐Orlow, M. K., Remillard, J. T., Bennett, I. M., Ben-Joseph, E. P., Batista, R. M., HYDE, J. N., & Rudd, R. E. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0803-x · Cited by 165
C-reactive protein: binding to lipids and lipoproteins.
Pepys, M. B., Rowe, I. F., & Baltz, M. L. (1985) · PubMed · Cited by 164
Vascular Biomarkers and Surrogates in Cardiovascular Disease
Tardif, J.-C., Heinonen, T., Orloff, D., & Libby, P. (2006) · Circulation · doi:10.1161/circulationaha.105.598987 · Cited by 163
Han, P. K. J., Moser, R. P., & Klein, W. M. P. (2006) · Journal of Health Communication · doi:10.1080/10810730600637541 · Cited by 163
Wu, A. H. B., & Jaffe, A. S. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.10.016 · Cited by 161
on behalf of the Membership of the International Cancer Imaging Society, Husband, J. E., Schwartz, L. H., Spencer, J., Ollivier, L., King, D. M., Johnson, R., & Reznek, R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601843 · Cited by 161
Eggers, K. M., Lind, L., Ahlstrom, H., Bjerner, T., Ebeling Barbier, C., Larsson, A., Venge, P., & Lindahl, B. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn327 · Cited by 161
Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis
Je, J., Ee, P., & Db, P. (2004) · Cited by 160
Desar, I. M. E., van Herpen, C. M. L., van Laarhoven, H. W. M., Barentsz, J. O., Oyen, W. J. G., & van der Graaf, W. T. A. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.12.001 · Cited by 160
Dense low density lipoproteins and coronary artery disease
Krauss, R. M. (1995) · The American Journal of Cardiology · doi:10.1016/0002-9149(95)80012-h · Cited by 158
Taylor, K. E., Giddings, J. C., & van den Berg, C. W. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000164623.41250.28 · Cited by 158
Effect of Risk Communication Formats on Risk Perception Depending on Numeracy
Keller, C., & Siegrist, M. (2009) · Medical Decision Making · doi:10.1177/0272989x09333122 · Cited by 157
Cited by
Mozaffarian, D. (2016) · Circulation · doi:10.1161/circulationaha.115.018585 · Cited by 2,216
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Biomarkers and surrogate endpoints in clinical trials
Fleming, T. R., & Powers, J. H. (2012) · Statistics in Medicine · doi:10.1002/sim.5403 · Cited by 544
Thurston, G. D., Kipen, H., Annesi-Maesano, I., Balmes, J., Brook, R. D., Cromar, K., De Matteis, S., Forastiere, F., Forsberg, B., Frampton, M. W., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00419-2016 · Cited by 537
Treatment of stage IV periodontitis: The EFP S3 level clinical practice guideline
Herrera, D., Sanz, M., Kebschull, M., Jepsen, S., Sculean, A., Berglundh, T., Papapanou, P. N., Chapple, I., Tonetti, M. S., & Consultant, E. W. P. A. M. (2022) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13639 · Cited by 408
Metadata
- Venue
- National Academies Press eBooks
- Publisher
- National Academies Press
- Published
- 2010-06-25
- OpenAlex
- W1496978731
- Cited by
- 276
- References
- 333
- FWCI
- 25.07
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.